Log in
Enquire now

List of Altravax, Inc. patents

List of Altravax, Inc. patents
List of PharmAbcine patents
List of BroadLogic Network Technologies patents
List of Precision Fabrics Group patents
Irrigation venture capital investors
Organ transplantation venture capital investors
Patents where
Current Assignee
Name
is
‌
Altravax, Inc.
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9353158 Hepatitis B virus vaccines

Patent 9353158 was granted and assigned to Altravax, Inc. on May, 2016 by the United States Patent and Trademark Office.

‌
Altravax, Inc.
‌
Altravax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9353158
May 31, 2016
‌
US Patent 8715694 Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein

Patent 8715694 was granted and assigned to Altravax, Inc. on May, 2014 by the United States Patent and Trademark Office.

‌
Altravax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8715694
May 6, 2014
‌
US Patent 8158131 Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E protein

Patent 8158131 was granted and assigned to Altravax, Inc. on April, 2012 by the United States Patent and Trademark Office.

‌
Altravax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8158131
April 17, 2012
‌
US Patent 9186397 Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein

Patent 9186397 was granted and assigned to Altravax, Inc. on November, 2015 by the United States Patent and Trademark Office.

‌
Altravax, Inc.
‌
Altravax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9186397
November 17, 2015
‌
US Patent 8168772 Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shuffling

Patent 8168772 was granted and assigned to Altravax, Inc. on May, 2012 by the United States Patent and Trademark Office.

‌
Altravax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8168772
May 1, 2012
5 results
0 selected
5 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us